© Reuters. Bausch Health (BHC) Suspends IPO of Solta Due to Market Conditions
Bausch Health Companies Inc. (NYSE:) announced Thursday evening that it is suspending the previously stated plan to pursue an initial public offering (IPO) of its Solta Medical business, given the challenging market conditions and other factors.
According to the company, Solta will remain as part of Bausch Health as it believes the interests of the company’s stakeholders are best served in the near term by focusing on driving Solta’s revenue, profits, and cash flow while also achieving key operational and regulatory milestones.
Bausch Health will revisit alternative paths for Solta in the future.
By Davit Kirakosyan
Be the first to comment